According to a brand new examine revealed within the International Journal of Drug Policy, using prescription stimulants is decrease in states the place medical marijuana has been legalized, in comparison with states the place all marijuana use stays unlawful. The examine is titled Medical marijuana legal guidelines and medical and non-medical prescription stimulant use amongst a nationally consultant pattern of US adults: Potential spillover results by sexual id and gender.
For the examine researchers examined the affiliation between prescription stimulant use and state-level medical marijuana legalization legal guidelines.
“Medical prescription stimulant use was lower in MCL (medical cannabis legalization) states versus non-MCL states for heterosexual men (3.7 percent versus 4.6 percent) and women (4.2 percent versus 5.7 percent)”, states the examine. “Bisexual men’s medical stimulant use prevalence was 4.2 percent in MCL states versus 9.9 percent in non-MCL states: among women, it was 7.3 percent versus 8.6 percent. Among bisexual men, non-medical prescription stimulant use was 5.6 percent in MCL states versus 8.1 percent in non-MCL states; for bisexual women, it was 6.0 percent versus 7.9 percent.”
They conclude by stating: “The ‘spillover’ effect of MCL enactment on the use of substances besides cannabis should be explicitly tested in future studies.”
Below is the total summary of this examine:
Background: Medical marijuana legal guidelines (MMLs) can influence marijuana and opioid use, however the relationship between MMLs and different medicine, akin to prescription stimulants, stays unexamined. Because lesbian, homosexual and bisexual (LGB) people report increased ranges of prescription stimulant use than heterosexuals, we explored the connection between MMLs and past-year medical and non-medical stimulant use by sexual id and gender.
Methods: We pooled 2015-2017 National Survey on Drug Use and Health knowledge for adults (n = 126 463), and used survey-weighted multinomial logistic regression to estimate odds of past-year (a) medical prescription stimulant use, (b) non-medical prescription stimulant use and (c) non-medical versus medical stimulant use. We stratified by gender, adjusted for sociodemographic traits, and examined the interplay between MML state residence and sexual id.
Results: Bisexual males had increased medical (6.4% versus 4.1%; aROR=1.93[1.29-2.88]) and non-medical stimulant use 6.6% versus 2.4%; aROR=2.23[1.44-3.44]) than heterosexual males. Bisexual ladies had increased non-medical stimulant use (6.8% versus 1.6%; aROR=1.54[1.23-2.93] than heterosexual ladies. Female (aROR=0.70[0.62-0.78]) and male (aROR=0.74[0.66-0.82]) heterosexuals in MML states had decrease odds of medical stimulant use than in non-MML states. Bisexual males in MML states had decrease odds of medical (aROR=0.36[0.21-0.61]) and non-medical stimulant use (aROR=0.48[0.29-0.81]) than bisexual males in non-MML states. Similar patterns emerged for bisexual ladies’s non-medical use (aROR=0.57[0.40-0.81]).
Conclusion: Prescription stimulant use was increased in non-MML states for many LGB subgroups. MMLs might differentially influence stimulant use, primarily for bisexual women and men. States enacting MMLs ought to contemplate potential impacts on medicine aside from marijuana, particularly amongst LGB populations.